Effects on bone mass after eight years of hormonal replacement therapy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 6, 1997, Pages 702-707

  Eiken, P ^a   Nielsen, S Pors ^a   Kolthoff, N ^a  

^a HILLERØD HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; NORETHISTERONE ACETATE; PLACEBO; TRISEQUENS;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FOREARM; FRACTURE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; LONG TERM CARE; LUMBAR SPINE; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PHOTON ABSORPTIOMETRY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RADIUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ULNA; VERTEBRA BODY;

ABSORPTIOMETRY, PHOTON; AGED; BONE DENSITY; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; FEMALE; FEMUR; HUMANS; LUMBAR VERTEBRAE; POSTMENOPAUSE; PROSPECTIVE STUDIES; RADIUS; TIME FACTORS; ULNA;

EID: 0030999333     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11981.x     Document Type: Article

References (27)

1. Mazess RB. Bone density in diagnosis of osteoporosis: thresholds and breakpoints. Calcif Tissue Int 1987; 41: 117–118.
2. Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980; 1151–1153.
3. Hutchinson TA, Polansky SM, Feinstein AR. Post-menopausal oestrogen protect against fractures of the hip and distal radius. A case-control study. Lancet 1979; 2: 705–709.
4. Weiss NS, Ure CL, Ballard JH, Willams AR, Baling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N EngJ Med 1980; 303: 1195–1198.
5. Paganini-Hill A, Ross RK, Gerkins VR, Henderson BE, Arthur M, Mack TM. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981; 95: 28–31.
6. Kreiger N, Kelsey JL, Holford TR, O'Connor T. An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol 1982; 116: 141–148.
7. Naessen T, Persson I, Adami H-O, Bergstrom R, Bergkvist L. Hormone replacemnet therapy and risk of first hip fracture. A prospective, population-based cohort study. Ann Intern Med 1990; 113: 95–103.
8. Kiel DP, Baron JA, Anderson JJ, Hannan MT, Felson DT. Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women. Ann Intern Med 1992; 116: 716–721.
9. Lafferty FW, Fiske ME. Postmenopausal estrogen replacement: a long term cohort study. Am J Med 1994; 97: 66–77.
10. Maxim P, Ettinger B, Spitamy GM. Fracture protection provided by long-term estrogen treatment. Osteoporosis Int 1995; 5: 23–29.
11. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Ann Int Med 1995; 122: 9–16.
12. Munk-Jensen N, Pors Nielsen S, Obel EB, Bonne Eriksen P. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled study. BMJ 1988; 296: 1150–1152.
13. Pors Nielsen S, Barenholdt O, Hermansen F, Munk-Jensen N. Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment. Br J Obstet Gynaecol 1994; 101: 319–324.
14. Eiken P, Barenholdt O, Bjørn Jensen L, Gram J, Pors Nielsen S. Switching from DXA pencil-beam to fan-beam. I: studies in vitro at four centers. Bone 1994; 15: 667–670.
15. Eiken P, Kolthoff N. Compliance with long-term oral hormonal replacement therapy. Maturitas 1995; 22: 97–103.
16. Steiniche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Melsen F. A randomized study on the effects of oestrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone 1989; 10: 313–320.
17. Riss BJ, Thomsen K, Strøm V, Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone toss. Am J Obstet Gynecoli 1987; 156: 61–65.
18. Christiansen C, Riss BJ. 17β-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 1990; 71: 836–841.
19. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PWF, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N EngJ Med 1993; 329 1141–1146.
20. Eastrell R, Mosekilde Li, Hodgson SF, Riggs BL. Proportion of human vertebral body bone that is cancellous. J Bone Miner Res 1990; 5: 1237–1241.
21. Duboeuf F, Braillon P, Chapuy MC et al. Bone mineral density of the hip measured with dual-energy x-ray absorptiometry in normal elderly women and in patients with hip fracture. Osteoporosis Int 1991; 1: 242–249.
22. Melton LJ, Wahner HW, Riggs BL. Bone density measurement. J Bone Miner Res 1987; 3: 9–10.
23. Melton LJ, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL. Long-term fracture prediction by bone mineral assessed by different skeletal sites. J Bone Miner Res 1993; 8: 1227–1233.
24. Horsman A, Nordin BEC, Crilly RG. Effect on bone of withdrawal of oestrogen therapy. Lancet 1979; 2: 33.
25. Lindsay R, Hart DM, MacLean A, Clark AC, Krazewski A, Garwood J. Bone response to termination of estrogen treatment. Lancet 1978; 1: 1325–1327.
26. Christiansen C, Christiansen MS, Transbøl I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981; 1: 459–461.
27. Eiken P, Kolthoff N, Barenholdt O, Hermansen F, Pors Nielsen S. Switching from DXA pencil-beam to fan-beam. II: Studies in vivo. Bone 1994; 15: 671–676.